Cargando…
Instrument for Assessing Patients’ Desirability, Acceptability, and Adherence to Telemedicine in Diabetes: Development, Validity, and Reliability
PURPOSE: To develop, test, and validate an instrument for assessing patients’ desirability, acceptability, and adherence to telemedicine in diabetes. PATIENTS AND METHODS: A group of six experts defined the components that needed to be assessed when developing telemedicine platforms aimed at improvi...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8654690/ https://www.ncbi.nlm.nih.gov/pubmed/34898981 http://dx.doi.org/10.2147/PPA.S343869 |
_version_ | 1784611915511627776 |
---|---|
author | Patrascu, Raul Albai, Alin Braha, Adina Gaita, Laura Lazar, Sandra Potre, Ovidiu Timar, Bogdan |
author_facet | Patrascu, Raul Albai, Alin Braha, Adina Gaita, Laura Lazar, Sandra Potre, Ovidiu Timar, Bogdan |
author_sort | Patrascu, Raul |
collection | PubMed |
description | PURPOSE: To develop, test, and validate an instrument for assessing patients’ desirability, acceptability, and adherence to telemedicine in diabetes. PATIENTS AND METHODS: A group of six experts defined the components that needed to be assessed when developing telemedicine platforms aimed at improving the care of patients with diabetes. The resulting instrument was tested for reliability and construct validity of 114 patients with diabetes and re-tested for reproducibility and consistency on a sub-group of 34 patients. Based on the analysis, the questionnaire’s syntax, phrasing, and flow were improved to obtain optimal assessment results. RESULTS: The resulting questionnaire has three major sections: one for the main evaluated component (acceptability, desirability, and adherence to telemedicine in diabetes), one for collecting socio-economic and demographical information, and one for diabetes history-related data, respectively. The corresponding data for these sections are collected using 29 questions. The developed instrument has a good reliability (Cronbach’s alpha = 0.890), reproducibility (Total score 164 vs 166 points at re-test vs test; Mann–Whitney U p-value = 0.394) and external validity (Spearman’s rho = −0.580; p < 0.001 for correlation with Patient’s Health Questionnaire −9; and Spearman’s rho = −0.516; p < 0.001 for correlation with Generalized Anxiety Disorder – 7). CONCLUSION: The developed questionnaire is a valid and reliable instrument in assessing the patients’ acceptability, desirability, and adherence to telemedicine use in diabetes care. In addition, the use of this instrument in the development of telemedicine platforms may improve and optimize their usage by providing valuable information regarding patients’ preferences and specific needs. |
format | Online Article Text |
id | pubmed-8654690 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-86546902021-12-10 Instrument for Assessing Patients’ Desirability, Acceptability, and Adherence to Telemedicine in Diabetes: Development, Validity, and Reliability Patrascu, Raul Albai, Alin Braha, Adina Gaita, Laura Lazar, Sandra Potre, Ovidiu Timar, Bogdan Patient Prefer Adherence Original Research PURPOSE: To develop, test, and validate an instrument for assessing patients’ desirability, acceptability, and adherence to telemedicine in diabetes. PATIENTS AND METHODS: A group of six experts defined the components that needed to be assessed when developing telemedicine platforms aimed at improving the care of patients with diabetes. The resulting instrument was tested for reliability and construct validity of 114 patients with diabetes and re-tested for reproducibility and consistency on a sub-group of 34 patients. Based on the analysis, the questionnaire’s syntax, phrasing, and flow were improved to obtain optimal assessment results. RESULTS: The resulting questionnaire has three major sections: one for the main evaluated component (acceptability, desirability, and adherence to telemedicine in diabetes), one for collecting socio-economic and demographical information, and one for diabetes history-related data, respectively. The corresponding data for these sections are collected using 29 questions. The developed instrument has a good reliability (Cronbach’s alpha = 0.890), reproducibility (Total score 164 vs 166 points at re-test vs test; Mann–Whitney U p-value = 0.394) and external validity (Spearman’s rho = −0.580; p < 0.001 for correlation with Patient’s Health Questionnaire −9; and Spearman’s rho = −0.516; p < 0.001 for correlation with Generalized Anxiety Disorder – 7). CONCLUSION: The developed questionnaire is a valid and reliable instrument in assessing the patients’ acceptability, desirability, and adherence to telemedicine use in diabetes care. In addition, the use of this instrument in the development of telemedicine platforms may improve and optimize their usage by providing valuable information regarding patients’ preferences and specific needs. Dove 2021-12-04 /pmc/articles/PMC8654690/ /pubmed/34898981 http://dx.doi.org/10.2147/PPA.S343869 Text en © 2021 Patrascu et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Patrascu, Raul Albai, Alin Braha, Adina Gaita, Laura Lazar, Sandra Potre, Ovidiu Timar, Bogdan Instrument for Assessing Patients’ Desirability, Acceptability, and Adherence to Telemedicine in Diabetes: Development, Validity, and Reliability |
title | Instrument for Assessing Patients’ Desirability, Acceptability, and Adherence to Telemedicine in Diabetes: Development, Validity, and Reliability |
title_full | Instrument for Assessing Patients’ Desirability, Acceptability, and Adherence to Telemedicine in Diabetes: Development, Validity, and Reliability |
title_fullStr | Instrument for Assessing Patients’ Desirability, Acceptability, and Adherence to Telemedicine in Diabetes: Development, Validity, and Reliability |
title_full_unstemmed | Instrument for Assessing Patients’ Desirability, Acceptability, and Adherence to Telemedicine in Diabetes: Development, Validity, and Reliability |
title_short | Instrument for Assessing Patients’ Desirability, Acceptability, and Adherence to Telemedicine in Diabetes: Development, Validity, and Reliability |
title_sort | instrument for assessing patients’ desirability, acceptability, and adherence to telemedicine in diabetes: development, validity, and reliability |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8654690/ https://www.ncbi.nlm.nih.gov/pubmed/34898981 http://dx.doi.org/10.2147/PPA.S343869 |
work_keys_str_mv | AT patrascuraul instrumentforassessingpatientsdesirabilityacceptabilityandadherencetotelemedicineindiabetesdevelopmentvalidityandreliability AT albaialin instrumentforassessingpatientsdesirabilityacceptabilityandadherencetotelemedicineindiabetesdevelopmentvalidityandreliability AT brahaadina instrumentforassessingpatientsdesirabilityacceptabilityandadherencetotelemedicineindiabetesdevelopmentvalidityandreliability AT gaitalaura instrumentforassessingpatientsdesirabilityacceptabilityandadherencetotelemedicineindiabetesdevelopmentvalidityandreliability AT lazarsandra instrumentforassessingpatientsdesirabilityacceptabilityandadherencetotelemedicineindiabetesdevelopmentvalidityandreliability AT potreovidiu instrumentforassessingpatientsdesirabilityacceptabilityandadherencetotelemedicineindiabetesdevelopmentvalidityandreliability AT timarbogdan instrumentforassessingpatientsdesirabilityacceptabilityandadherencetotelemedicineindiabetesdevelopmentvalidityandreliability |